Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro-CHOP versus CHOP in previously untreated peripheral T-cell lymphoma
KCT0003956Phase 3Active, not recruiting
- Sponsor
- LYSARC
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by LYSARC. Started Nov 2013; status: active, not recruiting.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on KCT0003956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003956.